These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 18378680)

  • 1. Kinetic investigation of the inhibitory effect of gemcitabine on DNA polymerization catalyzed by human mitochondrial DNA polymerase.
    Fowler JD; Brown JA; Johnson KA; Suo Z
    J Biol Chem; 2008 May; 283(22):15339-48. PubMed ID: 18378680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Excision of 2',2'-difluorodeoxycytidine (gemcitabine) monophosphate residues from DNA.
    Gandhi V; Legha J; Chen F; Hertel LW; Plunkett W
    Cancer Res; 1996 Oct; 56(19):4453-9. PubMed ID: 8813140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Action of 2',2'-difluorodeoxycytidine on DNA synthesis.
    Huang P; Chubb S; Hertel LW; Grindey GB; Plunkett W
    Cancer Res; 1991 Nov; 51(22):6110-7. PubMed ID: 1718594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of a template-located 2',2'-difluorodeoxycytidine on the kinetics and fidelity of base insertion by Klenow (3'-->5'exonuclease-) fragment.
    Schy WE; Hertel LW; Kroin JS; Bloom LB; Goodman MF; Richardson FC
    Cancer Res; 1993 Oct; 53(19):4582-7. PubMed ID: 8402631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of gemcitabine and araC on in vitro DNA synthesis mediated by the human breast cell DNA synthesome.
    Jiang HY; Hickey RJ; Abdel-Aziz W; Malkas LH
    Cancer Chemother Pharmacol; 2000; 45(4):320-8. PubMed ID: 10755321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incorporation of gemcitabine and cytarabine into DNA by DNA polymerase beta and ligase III/XRCC1.
    Prakasha Gowda AS; Polizzi JM; Eckert KA; Spratt TE
    Biochemistry; 2010 Jun; 49(23):4833-40. PubMed ID: 20459144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular pharmacology of gemcitabine.
    Mini E; Nobili S; Caciagli B; Landini I; Mazzei T
    Ann Oncol; 2006 May; 17 Suppl 5():v7-12. PubMed ID: 16807468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction between DNA Polymerase lambda and anticancer nucleoside analogs.
    Garcia-Diaz M; Murray MS; Kunkel TA; Chou KM
    J Biol Chem; 2010 May; 285(22):16874-9. PubMed ID: 20348107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular effects of 2',2'-difluorodeoxycytidine (Gemcitabine) on DNA replication in intact HL-60 cells.
    Ross DD; Cuddy DP
    Biochem Pharmacol; 1994 Oct; 48(8):1619-30. PubMed ID: 7980627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New Mechanism of Gemcitabine and Its Phosphates: DNA Polymerization Disruption via 3'-5' Exonuclease Inhibition.
    Yang S; Luo D; Li N; Li C; Tang S; Huang Z
    Biochemistry; 2020 Nov; 59(45):4344-4352. PubMed ID: 33147009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Difluorodeoxyguanosine: cytotoxicity, metabolism, and actions on DNA synthesis in human leukemia cells.
    Gandhi V; Mineishi S; Huang P; Yang Y; Chubb S; Chapman AJ; Nowak BJ; Hertel LW; Plunkett W
    Semin Oncol; 1995 Aug; 22(4 Suppl 11):61-7. PubMed ID: 7481847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Non-clinical studies of gemcitabine--the mode of action and antitumor activities].
    Tsukagoshi S
    Gan To Kagaku Ryoho; 1999 Feb; 26(3):393-400. PubMed ID: 10065109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incorporation and replication of 8-oxo-deoxyguanosine by the human mitochondrial DNA polymerase.
    Hanes JW; Thal DM; Johnson KA
    J Biol Chem; 2006 Nov; 281(47):36241-8. PubMed ID: 17005553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interference of gemcitabine triphosphate with the measurements of deoxynucleotides using an optimized DNA polymerase elongation assay.
    Smid K; Van Moorsel CJ; Noordhuis P; Voorn DA; Peters GJ
    Int J Oncol; 2001 Jul; 19(1):157-62. PubMed ID: 11408937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sublethal concentrations of gemcitabine (2',2'-difluorodeoxycytidine) alter mitochondrial ultrastructure and function without reducing mitochondrial DNA content in BxPC-3 human pancreatic carcinoma cells.
    Yeo TK; Kintner J; Armand R; Perez R; Lewis LD
    Hum Exp Toxicol; 2007 Dec; 26(12):911-21. PubMed ID: 18375634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinetic Investigation of Translesion Synthesis across a 3-Nitrobenzanthrone-Derived DNA Lesion Catalyzed by Human DNA Polymerase Kappa.
    Phi KK; Smith MC; Tokarsky EJ; Suo Z
    Chem Res Toxicol; 2019 Aug; 32(8):1699-1706. PubMed ID: 31286773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A phase I clinical, plasma, and cellular pharmacology study of gemcitabine.
    Abbruzzese JL; Grunewald R; Weeks EA; Gravel D; Adams T; Nowak B; Mineishi S; Tarassoff P; Satterlee W; Raber MN
    J Clin Oncol; 1991 Mar; 9(3):491-8. PubMed ID: 1999720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gemcitabine: metabolism, mechanisms of action, and self-potentiation.
    Plunkett W; Huang P; Xu YZ; Heinemann V; Grunewald R; Gandhi V
    Semin Oncol; 1995 Aug; 22(4 Suppl 11):3-10. PubMed ID: 7481842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preclinical characteristics of gemcitabine.
    Plunkett W; Huang P; Gandhi V
    Anticancer Drugs; 1995 Dec; 6 Suppl 6():7-13. PubMed ID: 8718419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between antiviral activity and host toxicity: comparison of the incorporation efficiencies of 2',3'-dideoxy-5-fluoro-3'-thiacytidine-triphosphate analogs by human immunodeficiency virus type 1 reverse transcriptase and human mitochondrial DNA polymerase.
    Feng JY; Murakami E; Zorca SM; Johnson AA; Johnson KA; Schinazi RF; Furman PA; Anderson KS
    Antimicrob Agents Chemother; 2004 Apr; 48(4):1300-6. PubMed ID: 15047533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.